Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 3,328 | 2,938 | 2,272 | 2,124 | 2,512 |
| Cost of Goods | 2,014 | 1,736 | 1,344 | 1,266 | 1,503 |
| Gross Profit | 1,313 | 1,202 | 928 | 858 | 1,009 |
| Operating Expenses | 5,272 | 5,675 | 6,763 | 5,282 | 5,643 |
| Operating Income | -3,944 | -3,737 | -5,491 | -4,159 | -4,131 |
| Interest Expense | 628 | 606 | 538 | 467 | 464 |
| Other Income | 13 | 12 | 17 | 13 | 12 |
| Pre-tax Income | -4,559 | -4,331 | -6,012 | -4,613 | -4,583 |
| Net Income Continuous | -4,559 | -4,331 | -6,012 | -4,613 | -4,583 |
| Net Income | $-4,559 | $-4,331 | $-6,012 | $-4,613 | $-4,583 |
| EPS Basic Total Ops | -0.34 | -0.34 | -0.50 | -0.43 | -0.44 |
| EPS Basic Continuous Ops | -0.34 | -0.34 | -0.50 | -0.43 | -0.45 |
| EPS Diluted Total Ops | -0.34 | -0.34 | -0.50 | -0.43 | -0.44 |
| EPS Diluted Continuous Ops | -0.34 | -0.34 | -0.50 | -0.43 | -0.45 |
| EBITDA(a) | $-3,668 | $-3,467 | $-5,250 | $-3,942 | $-3,941 |